Stock detail

Deva Holding A.Ş.

DEVASTOCKS | TR | IST | Healthcare | Drug Manufacturers - Specialty & Generic

Profile snapshotTRY 80.5Market cap TRY 16.1B

No local candle data found.

Recent detected patterns / setups

Latest 10 Market Radar results for this symbol and selected direction.

PatternTFScan runQuality

BullishICT BOS Retest Setup4H07 Nov 26, 16:1678

BullishOliver Kell Momentum Setup4H07 Nov 26, 16:1678

BearishICT Optimal Trade Entry (OTE) Setup4H07 Nov 26, 16:1689

BearishICT Inverse FVG Setup4H07 Nov 26, 16:1699

BearishFibonacci Retracement Setup4H07 Nov 26, 16:16100

BearishICT Inverse FVG Setup15M06 Nov 26, 20:1870

BullishSupport/Resistance Flip Setup15M06 Nov 26, 20:1882

BullishOliver Kell Momentum Setup15M06 Nov 26, 20:1882

BullishICT BOS Retest Setup1D06 Nov 26, 15:2387

BearishICT Optimal Trade Entry (OTE) Setup1D06 Nov 26, 15:2390

About Deva Holding A.Ş.

Deva Holding A.Ş. (DEVA) is listed on IST. Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; systemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary systems, connective tissue, and sensory organs. In addition, the company offers various products in sterile and non-sterile forms, including liquids, semi-solids, solids, cephalosporins, penicillin, hormone and inhalation products, solid and liquid oncology, animal health products, active pharmaceutical ingredients, ampoules, liquid and lyophilized vials, eye drops, and medical ampoules for sterile injectable products, as well as cologne. It also exports its products to approximately 60 countries. The company was incorporated in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of Eastpharma S.à R.L.

Annual

Annual fundamentals

2025 vs previous annual period

Total revenueTRY 19.2B-4.9%

Net incomeTRY -807M-988.1%

Net profit margin-4.2%-4.6 pp

EPS-4.03-995.6%

Total debtTRY 6B-25.9%

Cash and cash equivalentsTRY 2.4B+88.9%

Net debtTRY 3.6B-47.1%

Metric20212022202320242025

Total revenue----TRY 8.7B--TRY 16.4B+87.8%TRY 20.2B+23.7%TRY 19.2B-4.9%

Net income----TRY 851.1M--TRY 4.9B+474.3%TRY 90.9M-98.1%TRY -807M-988.1%

Net profit margin----9.8%--29.9%+205.9%0.4%-98.5%-4.2%-1033.7%

EPS----4.26--24.44+473.7%0.45-98.2%-4.03-995.6%

Free cash flow----TRY -42.8M--TRY 3.5B+8200.2%TRY 5.6B+63.0%TRY 2.9B-48.3%

Total debt----TRY 5.6B--TRY 7.9B+41.4%TRY 8.1B+1.9%TRY 6B-25.9%

Cash and cash equivalents----TRY 990.7M--TRY 2.2B+121.0%TRY 1.3B-42.3%TRY 2.4B+88.9%

Net debt----TRY 4.6B--TRY 5.7B+24.3%TRY 6.8B+18.8%TRY 3.6B-47.1%

Quarterly

Quarterly fundamentals

Q2 2026 vs same quarter previous year

Total revenueTRY 6B+1.6%

Net incomeTRY 614M+775.6%

Net profit margin10.2%+11.8 pp

EPS0.03+106.8%

Total debtTRY 6.3B-6.1%

Cash and cash equivalentsTRY 2.4B-35.1%

Net debtTRY 3.8B+31.8%

MetricQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Total revenue----TRY 5.5B--TRY 4.5B--TRY 5.5B--TRY 5.9B--TRY 6B+8.4%

Net income----TRY 659.7M--TRY -20.8M--TRY -1.3B--TRY -90.9M--TRY 614M-6.9%

Net profit margin----11.9%---0.5%---24.5%---1.5%--10.2%-14.1%

EPS0.12--0.03---0.1-------0.45-475.0%0.03-7.0%

Free cash flow----TRY 1.9B--TRY -4B--TRY 1.1B--TRY 675.5M--TRY 350.3M-81.3%

Total debt----TRY 5.1B--TRY 5.1B--TRY 6B--TRY 6.7B--TRY 6.3B+23.7%

Cash and cash equivalents----TRY 1.4B--TRY 1.7B--TRY 2.4B--TRY 3.8B--TRY 2.4B+73.4%

Net debt----TRY 3.7B--TRY 3.4B--TRY 3.6B--TRY 2.9B--TRY 3.8B+4.5%

Ownership

Institutional ownership summary

2026 Q4, quarter ended 2026-11-06

PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call